Skip to content

Released Mar 28, 2023, before the open

10-K filed Mar 29, 2023, 88 days after period end · 0000868278-23-000004

Q4 2022 · 10-K

derived · Computed from the longer spans the company filed.

Revenue$21.82Mderived−51.7% vs Q4 2021−9.8% vs Q3 2022
Net Income-$2.45MderivedN/M vs Q4 2021N/M vs Q3 2022
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$11,284,000−54.2%
Operating Incomederived-$5,091,000N/M
Operating Cash Flowderived$811,000N/M
Free Cash Flowderived-$785,000N/M
Margins · derived
Gross margin51.7%−2.8 pt vs Q4 2021
Operating margin-23.3%−53.6 pt vs Q4 2021
Net margin-11.2%−34.7 pt vs Q4 2021

What the release said

The release

Same quarter

MetricQ4 2022derived from reported figuresQ4 2021derived from reported figuresQ4 2020derived from reported figuresQ4 2019derived from reported figures
Revenue$21.82M$45.16M$5.16M$3.14M
Net Income-$2.45M$10.59M-$978.00K-$467.00K

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR